Prothena | PRTA - Les Charges D'Exploitation

Prix De L'Action
8.57
Variation Quotidienne
-0.25 -2.83%
Mensuellement
-4.46%
Annuel
-35.76%
Q1 Prévisions
8.48




Les Charges D'Exploitation Changement Date
Acadia Pharmaceuticals USD 266.6M 23.72M 2025-12
Agios Pharmaceuticals USD 141.54M 11.8M 2025-12
Akebia Therapeutics USD 63.08M 8.26M 2025-12
ALKERMES USD 326.44M 1.41B 2025-12
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
Amgen USD 5.9B 773M 2025-12
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Exelixis USD 362.75M 21.35M 2025-12
Immunic USD 25.73M 2.91M 2024-09
Incyte USD 1.12B 3.53B 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
MacroGenics USD 53.32M 13.68M 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neurocrine Biosciences USD 577.6M 22M 2025-12
Prothena USD 27.23M 14.95M 2025-12
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Ultragenyx Pharmaceutical USD 321M 9.82M 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12
Xoma USD 22.84M 1.67M 2024-09